2025年-2035年白色生物技术:技术、预测、市场、参与者

化工和材料应用的工业生物制造。工业发酵过程。超35种生物制造分子的技术分析与展望。生物制造市场评估及10年市场预测。

显示全部 说明 内容、图表列表 常见问题解答 价格 Related Content
白色生物技术产业的生产规模正持续扩张,生物制造化学品市场预计将在未来十年内以11.1%的复合年增长率实现增长。这一增长趋势主要源于监管层面的压力以及向生物基工业生产流程的转型。在本报告中,IDTechEx深入剖析了生物化学品制造的最新动态,覆盖了35种以上的生物基产品,并全面探讨了关键应用领域。报告对酶工程、合成生物学等关键支撑技术进行了评估,同时考察了原料来源、可持续性及终端应用情况。此外,报告还详细探讨了主要市场参与者、近期工厂关闭事件、商业化面临的挑战,以及影响该行业发展的不断演变的监管环境。
  • 在生物经济框架下探讨白色生物技术。
  • 概述生物制造在燃料、塑料、纺织品、添加剂、前体及其他化学品中的应用。
  • 识别通过生物制造生产的40多种生物基分子。
  • 针对主要生物制造分子的30多项详细技术分析,包括生物制造工艺、技术就绪水平、挑战、与石油基产品的对比及下游应用。
  • 对丙二醇、聚羟基脂肪酸酯(PHAs)、己二酸等主要生物基分子的当前产能与未来展望进行基准评估。
  • 分析合成生物学及其对工业生物制造的影响。
  • 影响白色生物技术的技术发展,包括碳捕集、气态与木质纤维素原料、新型生物催化剂。
  • 人工智能与机器学习对生物制造的技术影响。
  • 评估白色生物技术的市场驱动因素(政府立法、品牌、公众)与关键技术挑战。
  • 影响工业生物制造经济可行性的痛点。
  • 讨论白色生物技术的当前项目与既往努力,包括成功或失败因素分析。
  • 按主要生物制造分子(乳酸、丁二醇、PHAs、琥珀酸及其他有机酸等)细分的10年市场预测。
  • 识别100多家涉足工业生物制造的新兴初创企业与成熟参与者,按分子类别划分。
 
本报告涵盖以下内容:
  • 执行摘要与结论
  • 白色生物技术的新兴技术趋势
• 合成生物学
• 生物催化剂
• 无细胞系统
• 可持续性
• 替代原料
  • 白色生物技术的关键产品
• 燃料(乙醇、藻类生物燃料等)
• 聚合物前体(乳酸、琥珀酸、丁二醇、己二酸等)
• 其他化学品(有机酸、甘油三酯、脂肪酸等)
• 新型高性能材料(蛛丝蛋白、菌丝体等)
  • 白色生物技术市场分析-市场驱动因素、经济可行性与技术挑战
  • 工业生物制造的初创企业及参与者格局
  • 基于访谈的公司简介
  • 白色生物技术10大细分领域的市场规模、预测与展望
 
White biotechnology: Advancing the bioeconomy
The bioeconomy can be defined as an economic system in which society uses renewable biological resources (i.e. derived from land, fisheries, and aquaculture environments) to create biobased products such as food and nutrients, chemicals and materials, and bio-energy. Developing the bioeconomy is a key aspect of creating a more circular sustainable economy, an especially critical task as the effects of climate change are exacerbated by global reliance on fossil fuel resources.
 
The advancement of biotechnology is critical to expanding the bioeconomy, as different areas (or "colors") of biotechnology can positively improve different sectors of the economy. For example, "green" biotechnology may be used to improve agricultural yields, while "red" biotechnology may be applied towards the creation of new vaccines. Of the numerous colors of the biotechnology spectrum, white biotechnology stands out as a key technology enabler for the bioeconomy by advancing the industrial production of biobased products through biological systems.
 
In this report, "White Biotechnology 2025-2035", IDTechEx provides independent analysis of the status of white biotechnology, looking critically at technology innovations and historic, current, and future projects to provide an objective assessment of white biotechnology's future.
 
What is white biotechnology, and why does it matter?
White biotechnology, sometimes called industrial biomanufacturing, is the industrial production and processing of chemicals, materials, and energy using living cell factories, like bacteria, yeast, and fungi. White biotechnology represents a more sustainable alternative to petroleum-based chemical production: one that not only decreases society's reliance on fossil fuels but also uses less energy, generates less waste, and potentially creates biodegradable products that are better for the environment.
 
Current distribution of white biotechnology installed production capacity by region 2025. Source: IDTechEx
 
White biotechnology is not particularly new; engineered enzymes for detergents have been produced via white biotechnology since the 1980s, and bacterial enzymes have been used as food additives for many, many years. That begs the question: why is white biotechnology so interesting now?
 
IDTechEx, in this report, sheds light on the technology innovations driving white biotechnology's growth and increasing relevance. With improvements in biotechnology tools and processes comes the ability to produce numerous important products, from commodity chemicals to high performance textiles, through white biotechnology. One main technology driver is synthetic biology - the artificial design and engineering of biological systems and living organisms for the purpose of improving applications for industry or research. IDTechEx offers extensive discussion on synthetic biology's importance to industrial biomanufacturing by considering synthetic biology's tools and techniques, applications, emerging players, etc. IDTechEx continues their analysis of the technology advances enabling white biotechnology with detailed examinations (including status, technical benefits and challenges, commercial activity), among other trends, of:
  • Novel biocatalysts for industrial fermentation
  • Improvements to bioprocesses
  • Cell-free systems
  • Alternative feedstocks for bioreactors - gases, cellulosic materials, etc.
  • Carbon neutral and carbon negative biomanufacturing
 
Biobased products from industrial biomanufacturing: a diverse spectrum
Just as important as the innovations improving white biotechnology are its applications - the chemicals, precursors, additives, and materials produced by the fermentation of engineered cell factories. The range of molecules and compounds that can be biomanufactured is incredibly diverse with use cases in everything from lubricants to leather, textiles to packaging, adhesives to additives, etc. These molecules include alcohols, diols, diamines, organic acids, proteins, and more.
 
To provide clarity on these many products of white biotechnology, IDTechEx provides detailed technical and market analysis on 40+ biomanufactured molecules, looking at essential factors for each molecule such as:
  • The molecule's biomanufacturing process
  • Comparison of the biomanufactured product with its petrochemical equivalent
  • Technical advantages of the biomanufacturing process
  • Current challenges
  • Downstream products and end-applications for the molecule
  • Technology readiness level
  • Players developing and producing the molecule via biomanufacturing
  • Market outlook
 
With these IDTechEx insights, a clear understanding of the status and growing versatility of the white biotechnology industry will be achieved.
 
Lactic acid: Experiencing accelerating growth through regulation-driven PLA demand
Among the many biobased molecules covered in this report, lactic acid stands out for its rapidly growing significance, driven largely by increased demand for polylactic acid (PLA). PLA, a biodegradable polymer derived from lactic acid, is gaining momentum as a substitute for traditional fossil-based plastics in packaging and consumer goods. This surge in demand is notably influenced by tightening environmental regulations, particularly in China, where restrictions on non-biodegradable plastics have spurred a national push toward compostable alternatives. As a result, both domestic and international PLA producers are scaling up production capacity, fueling parallel growth in the lactic acid supply chain.
 
The Impact of AI on White Biotechnology
Artificial intelligence (AI) is increasingly becoming a pivotal enabler in the development and optimization of white biotechnology. By accelerating strain engineering, AI algorithms can analyze genomic and metabolic datasets to predict optimal genetic modifications for improved yield, tolerance, or productivity in microbial cell factories. In bioprocess development, machine learning models are being used to optimize fermentation conditions in silico, reducing the need for costly and time-consuming laboratory trials. AI also plays a vital role in enzyme discovery and protein engineering by rapidly screening candidate molecules for industrial use. As white biotechnology continues to expand its application scope, the integration of AI stands to dramatically improve process efficiency, scalability, and cost effectiveness, reinforcing the field's value proposition as a sustainable alternative to traditional petrochemical production.
 
White biotechnology: An active market of established and emerging players
With the diverse spectrum of molecules being produced through white biotechnology, there is a large number of companies attempting to advance their industrial biomanufacturing activities. Within this report, IDTechEx has considered well over 100 companies pursuing white biotechnology efforts, ranging from multinational material and chemical conglomerates to nascent startups. Important information such as partnerships, funding, past projects, molecules being pursued, current production capacity, and more are highlighted to understand how and why so many companies have chosen to engage with white biotechnology. These will be bolstered by IDTechEx's interview-based company profiles of key players in this market.
 
The player landscape of white biotechnology is just one component of the overall market dynamics that are shaping industrial biomanufacturing. There are numerous factors to be evaluated to determine the economic viability of certain white biotechnology projects, from internal factors such as process yield, ease of scale, and biocatalyst choice to external factors such as government regulations, crude oil prices, and the green premium. This report analyzes the white biotechnology market from these perspectives to offer understanding on the industry's prior trajectory and insight on what will determine its future success.
 
White biotechnology 10-year market forecast segmented by major molecules
 
Colors of biotechnology: defining the scope of white biotechnology. Source: IDTechEx
 
Lastly, to identify the growth potential of the white biotechnology industry, IDTechEx provides industrial biomanufacturing forecasts that segments the market by ten major biomanufactured molecules based on global production capacity. The report looks at the current capacity, drivers, and constraints of each segment and then extrapolates them into a 10-year forecast, to explore the mature and emerging white biotechnology products, technology readiness, potential for disruption, and the future landscape of white biotechnology.
Key Aspects:
  • Discussion of white biotechnology within the bioeconomy.
  • Overview of biomanufacturing's application in fuels, plastics, textiles, additives, precursors, and other chemicals.
  • Identification of 40+ biobased molecules produced through biomanufacturing.
  • 30+ granular technology analyses for major biomanufactured molecules, including biomanufacturing process, technology readiness level, challenges, comparison against petroleum incumbent, and downstream applications.
  • Benchmarking of current production capacity and outlook for major biobased molecules, including propanediol, PHAs, adipic acid, etc.
  • Analysis of synthetic biology and its impact on industrial biomanufacturing.
  • Technology developments influencing white biotechnology, including carbon capture, gaseous and lignocellulosic feedstock, and novel biocatalysts.
  • The impact of technology developments with AI and machine learning on biomanufacturing.
  • Assessment of market drivers (government legislation, brands, the public) and key technical challenges for white biotechnology.
  • Pain points affecting economic viability for industrial biomanufacturing.
  • Discussion of current projects and previous efforts in white biotechnology, including analysis of factors for success or failure.
  • Detailed 10-year market forecasts segmented by major biomanufactured molecules, including lactic acid, butanediol, PHAs, succinic acid, and other organic acids.
  • Identification of 100+ emerging startups and established players operating in industrial biomanufacturing, segmented by molecule.
Report MetricsDetails
CAGRBiomanufactured chemicals to grow at 11.1% CAGR from 2025-2035 (excluding fuels).
Forecast Period2025 - 2035
Forecast Unitskilotonnes per annum (ktpa)
Regions CoveredWorldwide
Segments CoveredLactic Acid, 1,3-propanediol, Long chain dicarboxylic acids (LCDAs), Succinic Acid, PHA, Other Biomanufactured Chemicals, Short chain fatty acids (SCFAS), 1,4-butanediol, 1,5-pentanediamine, Other organic acids
从 IDTechEx 访问分析师
所有报告购买订单均包括与一名专家分析师进行 30 分钟的电话交谈,专家分析师将帮助您将报告中的重要发现与您正在处理的业务问题联系起来。这需要在购买报告后的三个月内使用。
更多信息
如果您对这一报告有任何疑问,请随时联系我们的报告团队 research@IDTechEx.com 或致电我们的销售经理:

AMERICAS (USA): +1 617 577 7890
ASIA (Japan): +81 3 3216 7209
ASIA (Korea): +82 10 3896 6219
EUROPE (UK) +44 1223 812300
1.EXECUTIVE SUMMARY
1.1.Glossary of terms
1.2.Colors of biotechnology
1.3.What is white biotechnology?
1.4.White Biotechnology 2025-2035: scope
1.5.Trends and drivers in white biotechnology
1.6.Synthetic biology as applied to white biotechnology
1.7.Technology trends in white biotechnology
1.8.Overview of alternative feedstocks for white biotechnology
1.9.Major market challenges for white biotechnology
1.10.Technical challenges facing white biotechnology
1.11.Products derived from white biotechnology: Overview
1.12.Molecules that can be produced through industrial biomanufacturing
1.13.Molecules that can be produced through industrial biomanufacturing
1.14.Company landscape in white biotechnology
1.15.Company landscape in white biotechnology
1.16.Next-generation fuels through white biotechnology
1.17.Bioplastics through white biotechnology
1.18.Navigating biobased polymers from monosaccharides
1.19.Common bioplastics and polymer precursors synthesized via white biotechnology
1.20.Status of molecules produced through white biotechnology
1.21.White biotechnology market share by molecule 2025-2035
1.22.White biotechnology global capacity forecast 2025-2035
1.23.White biotechnology global capacity forecast 2025-2035: Discussion (I)
1.24.White biotechnology global capacity forecast 2025-2035: Discussion (II)
1.25.Emerging areas of white biotechnology forecast 2025-2035
1.26.IDTechEx circular bioeconomy research
1.27.Company profiles
1.28.Access More With an IDTechEx Subscription
2.INTRODUCTION
2.1.Glossary of acronyms
2.2.Glossary of acronyms
2.3.Glossary of terms
2.4.Glossary of terms
2.5.Colors of biotechnology
2.6.What is white biotechnology?
2.7.The bioeconomy and white biotechnology
2.8.White Biotechnology 2025-2035: Scope
3.MARKET ANALYSIS
3.1.Market Drivers for White Biotechnology
3.1.1.Market drivers: Demand for biobased products
3.1.2.Market drivers: Government regulation on petroleum-based plastic use
3.1.3.Market drivers: Regulations that are likely to impact biomanufacturing demand
3.1.4.Market drivers: Regulations are driving strong interest in biodegradable plastics in China
3.1.5.Market drivers: Government support of biotechnology
3.1.6.Market drivers: Government support of biotechnology
3.1.7.Market drivers: Carbon taxes
3.2.Economic Viability of White Biotechnology
3.2.1.Factors affecting the economic viability of white biotechnology projects
3.2.2.Effect of the price of Brent crude on biobased products
3.2.3.The Green Premium
3.2.4.Rising feedstock prices
3.2.5.Effect of cell factory on cost
3.2.6.Identifying the chemicals with the most potential to become biobased based on price
3.2.7.How scale-up affects cost
3.2.8.Zymergen: Case study on economics of synthetic biology
3.2.9.Case study: LanzaTech
3.2.10.Case study: Solazyme
3.2.11.Synthetic biology: Shift from commodity products to lower volume, high value markets
3.2.12.Major market challenges for white biotechnology
3.3.Player, Start-up, and Regional Landscape
3.3.1.Production capacity of chemicals from biomanufacturing by region 2025
3.3.2.Regional analysis: Drivers and restraints for biomanufacturing production and demand by region
3.3.3.Regional analysis: Location of R&D vs production
3.3.4.Regional analysis: Biomanufacturing
3.3.5.Regional analysis: Production capacity by region
3.3.6.Players: Synthetic biology tools and platforms
3.3.7.Players: Vertically integrated biomanufacturing
3.3.8.Emerging players segmented by molecule
3.3.9.Emerging players segmented by molecule
3.3.10.Overview of chemicals and materials companies involved with white biotechnology
3.3.11.Overview of chemicals and materials companies involved in white biotechnology
4.CELL FACTORIES FOR WHITE BIOTECHNOLOGY
4.1.Cell factories for biomanufacturing: Factors to consider
4.2.Cell factories for biomanufacturing: A range of organisms
4.3.Escherichia coli (E.coli)
4.4.Corynebacterium glutamicum (C. glutamicum)
4.5.Bacillus subtilis (B. subtilis)
4.6.Saccharomyces cerevisiae (S. cerevisiae)
4.7.Yarrowia lipolytica (Y. lipolytica)
4.8.Microorganisms used in different biomanufacturing processes
4.9.Non-model organisms for white biotechnology
5.TECHNOLOGY DEVELOPMENTS
5.1.Synthetic Biology
5.1.1.Synthetic biology: The design and engineering of biological systems
5.1.2.Synthetic biology: Manipulating the central dogma
5.1.3.The vast scope of synthetic biology
5.1.4.The process of synthetic biology: Design, build and test
5.1.5.Synthetic biology: Why now?
5.1.6.Synthetic biology: From pharmaceuticals to consumer products
5.1.7.Synthetic biology: Disrupting existing supply chains
5.1.8.Synthetic biology: Drivers and barriers for adoption
5.1.9.Synthetic biology as applied to white biotechnology
5.2.Tools and Techniques of Synthetic Biology
5.2.1.Tools and techniques of synthetic biology: Overview
5.2.2.DNA synthesis
5.2.3.Introduction to CRISPR-Cas9
5.2.4.CRISPR-Cas9: A bacterial immune system
5.2.5.CRISPR-Cas9's importance to synthetic biology
5.2.6.Protein/enzyme engineering
5.2.7.Computer-aided design
5.2.8.Commercial examples of engineered proteins in industrial applications
5.2.9.Strain construction and optimization
5.2.10.Synergy between synthetic biology and metabolic engineering
5.2.11.Framework for developing industrial microbial strains
5.2.12.The problem with scale
5.2.13.Introduction to cell-free systems
5.2.14.Cell-free versus cell-based systems
5.2.15.Cell-free systems in the context of white biotechnology
5.2.16.Cell-free systems for white biotechnology
5.2.17.Commercial implementation of cell-free systems: Solugen
5.2.18.Startups pursuing cell-free systems for white biotechnology
5.2.19.Startups pursuing cell-free systems for white biotechnology
5.2.20.Immobilized enzymes in white biotechnology
5.2.21.Immobilized catalysts in white biotechnology
5.2.22.Robotics: enabling hands-free and high throughput science
5.2.23.Robotic cloud laboratories
5.2.24.Automating organism design and closing the loop
5.2.25.Artificial intelligence and machine learning
5.2.26.Machine learning de novo protein prediction
5.2.27.Overview of machine learning based improvements for biomanufacturing
5.2.28.AI-driven fermentation platform companies
5.3.Improvement of Biomanufacturing Processes
5.3.1.Continuous vs batch biomanufacturing
5.3.2.Benefits and challenges of continuous biomanufacturing
5.3.3.Continuous vs batch biomanufacturing: Key fermentation parameter comparison
5.3.4.Machine learning to improve biomanufacturing processes
5.3.5.Downstream processing (DSP) improvements
5.3.6.Downstream processing (DSP) improvements (2)
5.3.7.Perfusion bioreactors
5.3.8.Tangential flow filtration (TFF) in downstream bioprocessing
5.3.9.Hybrid biotechnological-chemical approaches
5.3.10.Process intensification and high-cell-density fermentation
5.4.White Biotechnology for Sustainability
5.4.1.White biotechnology as a sustainable technology
5.4.2.Routes for carbon capture in white biotechnology
5.4.3.Autotrophic bacteria for carbon capture through biomanufacturing
5.5.Alternative Feedstocks for Biomanufacturing
5.5.1.Why use alternative feedstocks for white biotechnology?
5.5.2.Food, land, and water competition
5.5.3.C1 feedstocks: Metabolic pathways
5.5.4.C1 feedstocks: Economic benefits
5.5.5.C1 feedstocks: Challenges
5.5.6.Non-methane C1 feedstocks
5.5.7.C1 feedstocks: Products
5.5.8.C1 feedstocks: Gas fermentation
5.5.9.C2 feedstocks
5.5.10.C2 feedstocks: Products segmented by feedstock
5.5.11.C1 and C2 feedstocks: Commercial activity
5.5.12.C1 and C2 feedstocks: Commercial activity
5.5.13.Lignocellulosic biomass feedstocks
5.5.14.Lignocellulosic biomass feedstocks: Challenges
5.5.15.Lignocellulosic biomass feedstocks: Challenges
5.5.16.Lignocellulosic biomass feedstocks: Products
5.5.17.Lignocellulosic biomass feedstocks: Products
5.5.18.Lignocellulosic feedstocks: Commercial activity
6.BLUE BIOTECHNOLOGY
6.1.What is blue biotechnology?
6.2.Main biocatalysts of blue biotechnology: Cyanobacteria and algae
6.3.Cyanobacteria
6.4.Algae
6.5.Key drivers and challenges for blue biotechnology
6.6.Selected startups in blue biotechnology
7.PRODUCTS DERIVED FROM WHITE BIOTECHNOLOGY
7.1.1.Products derived from white biotechnology: Overview
7.2.Fuels
7.2.1.Biofuel generations - conventional & advanced biofuels
7.2.2.Biofuel generations
7.2.3.Biofuels made from white biotechnology
7.2.4.Metabolic pathways to biofuels
7.2.5.Bioethanol
7.2.6.Next-generation bioethanol
7.2.7.Next generation bioethanol: Barriers
7.2.8.Next-generation ethanol - operational plants
7.2.9.Next-generation ethanol - operational plants
7.2.10.Next-generation ethanol - operational plants
7.2.11.Next-generation ethanol - operational plants
7.2.12.Next-generation ethanol - operational plants
7.2.13.Next-generation ethanol - planned plants
7.2.14.Next-generation ethanol - planned plants
7.2.15.Next-generation ethanol - non-operational and cancelled plants
7.2.16.Next-generation ethanol - non-operational and cancelled plants
7.2.17.Diesel from biomanufacturing pathways
7.2.18.Farnesene
7.2.19.n-Butanol
7.2.20.Isobutanol
7.2.21.Methanol
7.2.22.Blue biotechnology in biofuel production
7.2.23.Blue biotechnology in biodiesel production
7.2.24.Blue biotechnology in bioethanol production
7.2.25.Blue biotechnology for biofuel production: Key challenges for commercial viability
7.2.26.Blue biotechnology for biofuel production: Commercial activity by US oil producers
7.2.27.Blue biotechnology for biofuel production: Commercial activity by non-US oil producers
7.2.28.Blue biotechnology for biofuel production: List of current and former players
7.2.29.Blue biotechnology for biofuel production: List of current and former players
7.2.30.Blue biotechnology for biofuel production: List of current and former players
7.3.Plastics and Textiles
7.3.1.Introduction to bioplastics
7.3.2.Production of bioplastics through white biotechnology
7.3.3.Navigating biobased polymers from monosaccharides
7.3.4.Common bioplastics and polymer precursors synthesized via white biotechnology
7.3.5.Lactic Acid and Polylactic Acid (PLA)
7.3.6.Lactic acid (C3H6O3)
7.3.7.Lactic acid: Bacterial fermentation or chemical synthesis?
7.3.8.Optimal lactic acid bacteria strains for fermentation
7.3.9.Engineering yeast strains for lactic acid fermentation
7.3.10.Fermentation, recovery and purification
7.3.11.What is polylactic acid?
7.3.12.Production of PLA
7.3.13.PLA production process
7.3.14.Polylactic acid: A SWOT analysis
7.3.15.Molecules for Other Biobased Synthetic Polyesters
7.3.16.The range of available biobased polyesters from bio-manufactured monomers
7.3.17.Propylene glycol (PG) or 1,2-propanediol
7.3.18.1,3-Propanediol (1,3-PDO)
7.3.19.Biobased PDO and PTT: Monomer production
7.3.20.Biobased PDO and PTT: Polymer applications
7.3.21.2,3-Butanediol (2,3-BDO)
7.3.22.1,4-Butanediol (1,4-BDO)
7.3.23.Biobased BDO: Monomer production
7.3.24.Biobased BDO technology licensed from Geno
7.3.25.Biobased BDO and PBT: Polymer applications
7.3.26.Succinic acid
7.3.27.Biobased succinic acid: Monomer production
7.3.28.Biobased succinic acid and PBS: Polymer applications
7.3.29.Biobased succinic acid: Project status
7.3.30.2,5-furandicarboxylic acid (FDCA)
7.3.31.Biobased FDCA: Monomer production
7.3.32.Polyethylene furanoate (PEF)
7.3.33.Biobased FDCA and PEF: Polymer applications
7.3.34.Molecules for Other Biobased Synthetic Polymers
7.3.35.Biosynthetic pathways to polyamides
7.3.36.C6: Adipic acid, hexamethylenediamine, and caprolactam
7.3.37.C10: Sebacic acid
7.3.38.C12: Dodecanedioic acid
7.3.39.1,5-Pentanediamine (PDA)
7.3.40.Covestro: PDI and Desmodur eco aliphatic polyisocyanate
7.3.41.Cathay Industrial Biotech: TERRYL and ECOPENT biobased polyamides
7.3.42.1,3-Butadiene
7.3.43.Status of biomanufacturing-derived butadiene projects
7.3.44.Isoprene
7.3.45.Isobutene (isobutylene)
7.3.46.Naturally Occurring Biobased Polymers: Polyhydroxyalkanoates (PHAs)
7.3.47.Introduction to poly(hydroxyalkanoates)
7.3.48.Biosynthetic pathways to PHAs
7.3.49.Fermentation, recovery and purification
7.3.50.Key commercial PHAs and microstructures
7.3.51.PHB, PHBV, and P(3HB-co-4HB)
7.3.52.Types of PHAs
7.3.53.Material properties of commercial PHAs
7.3.54.Suppliers of PHAs
7.3.55.Short and medium chain-length PHAs
7.3.56.PHAs: A SWOT analysis
7.3.57.Applications of PHAs
7.3.58.Opportunities in PHAs
7.3.59.Reducing the cost of PHA production
7.3.60.Risks in PHAs
7.3.61.PHAs are only made in small quantities
7.3.62.PHA production facilities
7.3.63.Case Study: Danimer Scientific ends PHA production
7.3.64.Conclusions
7.3.65.Other Textiles Produced through White Biotechnology
7.3.66.Spider silk
7.3.67.Collagen-derived textiles
7.3.68.Mycelium
7.4.Other Chemicals, Precursors, and Additives
7.4.1.Acetone
7.4.2.Acrylic acid
7.4.3.Acetone
7.4.4.Itaconic acid
7.4.5.Biobased ethanol as a precursor
7.4.6.Biomanufacturing of ethylene
7.4.7.Monoethylene glycol (MEG)
7.4.8.Biobased MEG: Monomer production
7.4.9.Biobased MEG: Industry landscape
7.4.10.Biobased MEG: Industry landscape
7.4.11.Polyethylene terephthalate (PET)
7.4.12.Biobased polyolefins
7.4.13.Braskem: "I'm green" polyethylene
7.4.14.Biomanufacturing of propylene precursors
7.4.15.Malonic acid
7.4.16.Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs)
7.4.17.Short chain fatty acids and medium chain fatty acids (SCFAs/MCFAs)
7.4.18.Short chain fatty acids: Acetic acid
7.4.19.Triglycerides
7.4.20.Other organic acids and aldehydes
7.4.21.Other organic acids and aldehydes
7.4.22.Bacterial cellulose
7.5.Other Products Derived from White Biotechnology
7.5.1.Overview of vitamins and amino acids produced through white biotechnology
7.5.2.Overview of white biotechnology for cosmetics
7.5.3.Biomanufacturing for surfactants and detergents
7.5.4.Enzymes for onward use: Novozymes
7.5.5.Cement alternatives from biomanufacturing: BioMason
7.5.6.Precision fermentation: Definition and scope
8.FORECASTS FOR WHITE BIOTECHNOLOGY
8.1.Forecast methodology
8.2.White biotechnology market share by molecule 2025-2035
8.3.White biotechnology global capacity forecast 2025-2035
8.4.White biotechnology global capacity forecast 2025-2035: Discussion (I)
8.5.White biotechnology global capacity forecast 2025-2035: Discussion
8.6.White biotechnology global capacity forecast 2025-2035: Discussion
8.7.Emerging areas of white biotechnology forecast 2025-2035
8.8.Emerging areas of white biotechnology forecast: Discussion
9.COMPANY PROFILES
9.1.Afyren
9.2.Arzeda
9.3.Biomason
9.4.Bolt Threads
9.5.Braskem
9.6.Cathay Biotech
9.7.CarbonBridge
9.8.Celtic Renewables
9.9.Chaincraft
9.10.CyanoCapture
9.11.Ecovative
9.12.Enginzyme
9.13.Enzymaster
9.14.Industrial Microbes
9.15.Kraig Biocraft Laboratories
9.16.LanzaTech (2023) Update
9.17.LanzaTech
9.18.Mango Materials
9.19.Modern Meadow
9.20.New Energy Blue
9.21.Novozymes
9.22.Q Power
9.23.Spiber
9.24.Henan Techuang Biotechnology
9.25.Huitong Biomaterials
9.26.Total Energies Corbion
9.27.Teijin Frontier: PLA
9.28.Natureworks
9.29.Biotic Circular Technologies
9.30.Bluepha
9.31.CJ Biomaterials
9.32.Danimer Scientific (2024 Update - Now bankrupt)
9.33.Danimer Scientific
9.34.Fortum: INGA Plastic
9.35.Kaneka
9.36.Newlight Technologies (Not currently operational)
9.37.Ourobio
9.38.Paques Biomaterials
10.APPENDIX
10.1.White biotechnology global capacity forecast 2025-2035
10.2.Emerging areas of white biotechnology forecast 2025-2035
 

About IDTechEx reports

What are the qualifications of the people conducting IDTechEx research?

Content produced by IDTechEx is researched and written by our technical analysts, each with a PhD or master's degree in their specialist field, and all of whom are employees. All our analysts are well-connected in their fields, intensively covering their sectors, revealing hard-to-find information you can trust.

How does IDTechEx gather data for its reports?

By directly interviewing and profiling companies across the supply chain. IDTechEx analysts interview companies by engaging directly with senior management and technology development executives across the supply chain, leading to revealing insights that may otherwise be inaccessible.
 
Further, as a global team, we travel extensively to industry events and companies to conduct in-depth, face-to-face interviews. We also engage with industry associations and follow public company filings as secondary sources. We conduct patent analysis and track regulatory changes and incentives. We consistently build on our decades-long research of emerging technologies.
 
We assess emerging technologies against existing solutions, evaluate market demand and provide data-driven forecasts based on our models. This provides a clear, unbiased outlook on the future of each technology or industry that we cover.

What is your forecast methodology?

We take into account the following information and data points where relevant to create our forecasts:
  • Historic data, based on our own databases of products, companies' sales data, information from associations, company reports and validation of our prior market figures with companies in the industry.
  • Current and announced manufacturing capacities
  • Company production targets
  • Direct input from companies as we interview them as to their growth expectations, moderated by our analysts
  • Planned or active government incentives and regulations
  • Assessment of the capabilities and price of the technology based on our benchmarking over the forecast period, versus that of competitive solutions
  • Teardown data (e.g. to assess volume of materials used)
  • From a top-down view: the total addressable market
  • Forecasts can be based on an s-curve methodology where appropriate, taking into account the above factors
  • Key assumptions and discussion of what can impact the forecast are covered in the report.

How can I be confident about the quality of work in IDTechEx reports?

Based on our technical analysts and their research methodology, for over 25 years our work has regularly received superb feedback from our global clients. Our research business has grown year-on-year.
 
Recent customer feedback includes:
"It's my first go-to platform"
- Dr. Didi Xu, Head of Foresight - Future Technologies, Freudenberg Technology Innovation
 
"Their expertise allows us to make data-driven, strategic decisions and ensures we remain aligned with the latest trends and opportunities in the market."
- Ralf Hug, Global Head of Product Management & Marketing, Marquardt

What differentiates IDTechEx reports?

Our team of in-house technical analysts immerse themselves in industries over many years, building deep expertise and engaging directly with key industry players to uncover hard-to-find insights. We appraise technologies in the landscape of competitive solutions and then assess their market demand based on voice-of-the-customer feedback, all from an impartial point of view. This approach delivers exceptional value to our customers—providing high-quality independent content while saving customers time, resources, and money.

Why should we pick IDTechEx research over AI research?

A crucial value of IDTechEx research is that it provides information, assessments and forecasts based on interviews with key people in the industry, assessed by technical experts. AI is trained only on content publicly available on the web, which may not be reliable, in depth, nor contain the latest insights based on the experience of those actively involved in a technology or industry, despite the confident prose.

How can I justify the ROI of this report?

Consider the cost of the IDTechEx report versus the time and resources required to gather the same quality of insights yourself. IDTechEx analysts have built up an extensive contact network over many years; we invest in attending key events and interviewing companies around the world; and our analysts are trained in appraising technologies and markets.
 
Each report provides an independent, expert-led technical and market appraisal, giving you access to actionable information immediately, rather than you having to spend months or years on your own market research.

Can I speak to analysts about the report content?

All report purchases include up to 30 minutes of telephone time with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This needs to be used within three months of purchasing the report.

What is the difference between a report and subscription?

A subscription from IDTechEx can include more reports, access to an online information platform with continuously updated information from our analysts, and access to analysts directly.

Before purchasing, I have some questions about the report, can I speak to someone?

Please email research@idtechex.com stating your location and we will quickly respond.

About IDTechEx

Who are IDTechEx's customers?

IDTechEx has served over 35,000 customers globally. These range from large corporations to ambitious start-ups, and from Governments to research centers. Our customers use our work to make informed decisions and save time and resources.

Where is IDTechEx established?

IDTechEx was established in 1999, and is headquartered in Cambridge, UK. Since then, the company has significantly expanded and operates globally, having served customers in over 80 countries. Subsidiary companies are based in the USA, Germany and Japan.

Questions about purchasing a report

How do I pay?

In most locations reports can be purchased by credit card, or else by direct bank payment.

How and when do I receive access to IDTechEx reports?

When paying successfully by credit card, reports can be accessed immediately. For new customers, when paying by bank transfer, reports will usually be released when the payment is received. Report access will be notified by email.

How do I assign additional users to the report?

Users can be assigned in the report ordering process, or at a later time by email.

Can I speak to someone about purchasing a report?

Please email research@idtechex.com stating your location and we will quickly respond.
 

Ordering Information

2025年-2035年白色生物技术:技术、预测、市场、参与者

£$¥
电子版(1-5 名用户)
£5,650.00
电子版(6-10 名用户)
£8,050.00
电子版及 1 份硬拷贝文件(1-5 名用户)
£6,450.00
电子版及 1 份硬拷贝文件(6-10 名用户)
£8,850.00
电子版(1-5 名用户)
€6,400.00
电子版(6-10 名用户)
€9,100.00
电子版及 1 份硬拷贝文件(1-5 名用户)
€7,310.00
电子版及 1 份硬拷贝文件(6-10 名用户)
€10,010.00
电子版(1-5 名用户)
$7,000.00
电子版(6-10 名用户)
$10,000.00
电子版及 1 份硬拷贝文件(1-5 名用户)
$7,975.00
电子版及 1 份硬拷贝文件(6-10 名用户)
$10,975.00
电子版(1-5 名用户)
元50,000.00
电子版(6-10 名用户)
元72,000.00
电子版及 1 份硬拷贝文件(1-5 名用户)
元58,000.00
电子版及 1 份硬拷贝文件(6-10 名用户)
元80,000.00
电子版(1-5 名用户)
¥990,000
电子版(6-10 名用户)
¥1,406,000
电子版及 1 份硬拷贝文件(1-5 名用户)
¥1,140,000
电子版及 1 份硬拷贝文件(6-10 名用户)
¥1,556,000
电子版(1-5 名用户)
₩9,800,000
电子版(6-10 名用户)
₩14,000,000
电子版及 1 份硬拷贝文件(1-5 名用户)
₩11,200,000
电子版及 1 份硬拷贝文件(6-10 名用户)
₩15,400,000
Click here to enquire about additional licenses.
If you are a reseller/distributor please contact us before ordering.
お問合せ、見積および請求書が必要な方はm.murakoshi@idtechex.com までご連絡ください。
从2025年到2035年,生物制造化学品(不含燃料)将以11.1%的复合年增长率稳步发展。

报告统计信息

幻灯片 315
预测 2035
已发表 Apr 2025
 

预览内容

pdf Document Sample pages
 

Customer Testimonial

quote graphic
"IDTechEx consistently provides well-structured and comprehensive research reports, offering a clear and holistic view of key trends... It's my first go-to platform for quickly exploring new topics and staying updated on industry advancements."
Head of Foresight - Future Technologies
Freudenberg Technology Innovation SE & Co. KG
 
 
 
ISBN: 9781835701171

Subscription Enquiry